Nocturia

EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market

Retrieved on: 
Friday, March 29, 2024
Consumer Electronics, Health, Consumer, Technology, Women, Fitness & Nutrition, Hardware, KRW, Yong In University, Uterus, Exercise, Lifting, Relaxation, Beauty, Pelvis, Rectum, Pregnancy, PMS, Menstruation, Femininity, Nocturia, Uterine prolapse, Pelvic floor, Traction, Urinary incontinence, Elasticity, Premenstrual syndrome, EMS, Multimedia, Dietary supplement

This innovative solution enables people to do Kegel exercises easily by sitting on it, heralding a new era of K-HEALTH CARE.

Key Points: 
  • This innovative solution enables people to do Kegel exercises easily by sitting on it, heralding a new era of K-HEALTH CARE.
  • View the full release here: https://www.businesswire.com/news/home/20240327264174/en/
    The EMS Kegel Trainer BODYDOCTOR FEMFIT has been launched in Japan.
  • (Photo: GENERALNET CORP)
    Derived from combining 'Feminine' and 'Care', the term 'Femcare' encompasses products and services designed to care for women’s bodies and health.
  • Understanding how important it is to strengthen pelvic floor muscles to address these health issues, GENERALNET CORP, a company dedicated to women's health and beauty, launched the EMS Kegel exerciser BODYDOCTOR in January 2019.

Urine Charge! Urology Care Foundation Helps You Keep Your Bladder Healthy for Bladder Health Month

Retrieved on: 
Wednesday, November 1, 2023
Knowledge, Diet, UCF, MD, Woman, UTI, Bladder cancer, Risk, Nocturia, Interstitial, Exercise, Dietary supplement, Birth control

BALTIMORE, Nov. 1, 2023 /PRNewswire/ -- November 1 marks the beginning of Bladder Health Month, and this year, the Urology Care Foundation (UCF) wants you to know 'urine' control of keeping your bladder happy and healthy.

Key Points: 
  • BALTIMORE, Nov. 1, 2023 /PRNewswire/ -- November 1 marks the beginning of Bladder Health Month, and this year, the Urology Care Foundation (UCF) wants you to know 'urine' control of keeping your bladder happy and healthy.
  • Bladder issues are often not talked about because some might feel embarrassed or do not know that it could indicate a health issue.
  • "Promoting awareness of bladder health and urging individuals to engage in discussions with healthcare experts about their bladder health symptoms is a crucial initial measure in eradicating the stigma linked to conditions and diseases related to the bladder," explains Harris M. Nagler, MD, President of the Urology Care Foundation.
  • This lack of information is why every week this month, the Urology Care Foundation will spotlight bladder conditions that impact people in the U.S. and give tips on how to have that important conversation with your doctor.

Glycologix Treats First Patient in Pilot Study of GLX-100 for Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Retrieved on: 
Tuesday, October 24, 2023
Health, Surgery, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, IC/BPS, Nocturia, Pressure, Woman, Safety, Trial of the century, Biopolymer, Patient, Interstitial, Pharmaceutical industry

Glycologix, Inc. (“Glycologix”), a clinical-stage company focused on developing biopolymers for the protection and repair of soft tissues, today announced the treatment of the first patient in a pilot clinical study evaluating GLX-100 as a novel treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

Key Points: 
  • Glycologix, Inc. (“Glycologix”), a clinical-stage company focused on developing biopolymers for the protection and repair of soft tissues, today announced the treatment of the first patient in a pilot clinical study evaluating GLX-100 as a novel treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
  • The multi-center pilot trial is designed to assess the safety, tolerability and effectiveness of GLX-100 in participants with IC/BPS and is expected to enroll up to 40 women with results anticipated in 2024.
  • GLX-100 is a novel biopolymer, which has been designed to closely replicate the natural protective barrier layer and relieve the symptoms of IC/BPS.
  • We look forward to sharing the results from the study in 2024.”

Seoul St. Mary's Hospital Found Red Ginseng Oil is Excellent for Improving Prostatic Hyperplasia

Retrieved on: 
Thursday, September 14, 2023
Korea Ginseng Corporation, Retention rate, Urine, BPH, KGC, International Prostate Symptom Score, Nocturia, Research, Multimedia, JUNG, Malignancy, Capsule, Professor, Patient, Hospital, Department of Urology, University of Virginia, Ageing, Benign prostatic hyperplasia, Dietary supplement, IPSS

SEOUL, South Korea, Sept. 14, 2023 /PRNewswire/ -- Red ginseng oil has been found to be a safe and effective solution for improving prostatic hyperplasia for the first time.

Key Points: 
  • SEOUL, South Korea, Sept. 14, 2023 /PRNewswire/ -- Red ginseng oil has been found to be a safe and effective solution for improving prostatic hyperplasia for the first time.
  • Led by Professor Kim Sae Woong from the Department of Urology at Seoul St. Mary's Hospital, in collaboration with the Korea Ginseng Corporation (KGC), this research's results indicate that the intake of red ginseng oil extracted from JUNG KWAN JANG's RXGIN can safely and effectively improve prostatic hyperplasia.
  • It turns out that, compared to a mere 3.7% improvement in the control group, the red ginseng oil group experienced a significant 50.5% improvement in the red ginseng oil group in IPSS.
  • Professor Kim explained, "We found that red ginseng oil not only significantly improves the symptoms of BPH but also enhances dysfunction, which are the side effects of existing BPH(Benign prostatic hyperplasia) treatments."

Star Sleep & Wellness Opens to Offer Start-to-Finish, Comprehensive Sleep Therapy with 5 Locations in DFW

Retrieved on: 
Wednesday, July 19, 2023
Accident, Wellness, Bubble CPAP, Sleep, Weight loss, Nocturia, Sleep apnea, Insomnia, Patient, Practitioner, NPS, America's Health Rankings, Diagnosis, Fatigue, Nursing

DALLAS and FORT WORTH, Texas, July 19, 2023 /PRNewswire/ -- According to America's Health Rankings with the United Health Foundation, about 33.2 percent of Texans regularly get insufficient sleep in a 24-hour period. This means that up to a third of Texan residents may face issues like insomnia, loud snoring, sleep apnea, and nocturia every night. Without treatment, these sleep issues can lead to many health problems, including high blood pressure, mental illnesses, and extreme fatigue, as well as drowsy driving and auto accidents.

Key Points: 
  • To facilitate diagnosis and treatment of these conditions, Star Sleep & Wellness has recently opened five locations throughout Dallas Metroplex, namely in Dallas, Denton, Frisco, Irving, and Plano.
  • Unlike other sleep centers, Star Sleep & Wellness practices provide truly comprehensive services.
  • Instead of sending patients from specialist to specialist, Star Sleep & Wellness brings all the experts to the patient to provide the appropriate treatment(s).
  • If you struggle to get sufficient quality sleep, you are invited to contact one of the five locations of Star Sleep & Wellness for an appointment.

PHI Group, Inc. and Vietnam-based Saphia Alkali JSC Sign Agreement to Provide Innovative Proprietary Products for Healthcare, Agriculture, Aquaculture and the Environment to International Markets

Retrieved on: 
Wednesday, June 28, 2023
Osteoarthritis, JSC, Mineral, Arthritis, Agriculture, Aquaculture, Ageing, Nocturia, Cramp, Tropical ulcer, Hives, DSM-IV codes, Saphia Azzeddine, Vitamin, Regeneration, Patient, Love, Immune system, Kidney, Liver, Health, Environment, Atakent (business cooperation center), Fatigue, Glass fiber, Dietary supplement, Tanning (leather), Glycoside, Flavonoid, Saponin

According to the agreement, the companies have incorporated “Sapphire Alkali Global Group,” a Wyoming corporation, Registration ID 2023-001291498, as the parent company to implement this Business Cooperation Agreement.

Key Points: 
  • According to the agreement, the companies have incorporated “Sapphire Alkali Global Group,” a Wyoming corporation, Registration ID 2023-001291498, as the parent company to implement this Business Cooperation Agreement.
  • Current Saphia Alkali JSC’s reputable healthcare products include:
    Saphia Alkali Balance: a health supplement that aids in the treatment of metabolic disorders and imbalances in the body.
  • Saphia Alkali X300 (Saphia Alkali D-REVIE X300): a reputable health supplement that effectively supports antioxidant capacity, enhances health, helps improve resistance, and reduces fatigue.
  • Besides these and other healthcare-related products, Saphia Alkali JSC has also developed successful solutions for agriculture, aquaculture, and environment using its proprietary activated alkali technonogies.

Axonics to Participate in the SUFU 2023 Winter Meeting

Retrieved on: 
Tuesday, March 7, 2023
Medical Supplies, Medical Devices, Health, Health Technology, General Health, Biotechnology, Role, Physician, Effectiveness, Nocturia, Overactive bladder, Patient, Fecal incontinence, Incontinence, Urinary retention, SUFU, Quality of life, SNM, Society, Winter Meeting, Durability, OAB, Pharmaceutical industry, Axon reflex

In addition, data highlighting the experience of patients with Axonics SNM therapy will include three poster presentations:

Key Points: 
  • In addition, data highlighting the experience of patients with Axonics SNM therapy will include three poster presentations:
    The Role of Age in the Effectiveness of SNM for OAB – presented by Ayman Mahdy, M.D., Ph.D.
  • Effectiveness of the Axonics SNM System in Improving Sleep Quality of Life for Patients Suffering with Nocturia – presented by Michael Kennelly, M.D.
  • Efficacy and Durability of the Predictive Programming Algorithm of the Axonics SNM System – presented by Ryan Krlin, M.D.
  • “The SUFU 2023 Winter Meeting provides an opportunity for physicians to learn more about Axonics SNM therapy and the durable symptom relief patients are experiencing, directly from their peers,” said Karen Noblett, M.D., chief medical officer of Axonics.

Healthcare Veterans Launch Boom Home Medical to Revolutionize Home Medical Equipment

Retrieved on: 
Wednesday, January 11, 2023
Anatomy, Female, Sleep, News, LOS, Travel, Walking, Home medical equipment, Entrepreneurship, FAQ, Camping, Nocturia, Amazon, Urination, Grandparent, Hospital, Medicine, Loona, Molekule

LOS ANGELES, Jan. 11, 2023 /PRNewswire/ -- Today, Founders of Clear Health Advisors, Byrdie Lifson Pompan and Dr. Valerie Ulene, launched Boom Home Medical – a company with a mission to radically reinvent home medical products with beautifully designed, highly functional, and easy-to-use products that empower people to care for themselves with dignity. 

Key Points: 
  • Boom Home Medical's reimagined home medical products are designed to fit perfectly into consumers' lives and homes.
  • The company launches with toileting products and will be rolling out a lineup of innovative bathing, dressing, and mobility products throughout 2023.
  • Baby boomers have experienced innovation in every consumer product category, and now can experience it in home healthcare products too.
  • Roughly 50 million Americans wake up several times a night with the urge to urinate, a medical condition called nocturia .

InventHelp Inventor Develops Improved Incontinence Product (SDB-1678)

Retrieved on: 
Monday, November 7, 2022
Infection, DEPT, Multimedia, Sale, Incontinence, Nocturia, Incidence, Pain, Ninth Street, Disease, Patient, Medical imaging

PITTSBURGH, Nov. 7, 2022 /PRNewswire/ -- "I'm a registered nurse and I thought there could be a better incontinence product for patients," said an inventor, from San Diego, Calif., "so I invented the INCONTINENCE PRODUCT.

Key Points: 
  • PITTSBURGH, Nov. 7, 2022 /PRNewswire/ -- "I'm a registered nurse and I thought there could be a better incontinence product for patients," said an inventor, from San Diego, Calif., "so I invented the INCONTINENCE PRODUCT.
  • My design could help to reduce complications, morbidity and health care costs associated with traditional catheters."
  • The original design was submitted to the San Diego sales office of InventHelp.
  • 21-SDB-1678, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Ur24Technology and DemeTECH Partner to Combine Market-altering Innovation With Renowned Leadership in Surgical Products and Global Distribution

Retrieved on: 
Thursday, November 3, 2022
Surgery, Medical Devices, Women, Baby, Maternity, Men, Health Technology, Health, Consumer, General Health, Leadership, Nocturia, Jimmy Cauty, Inc., Pediatrics, Catheter-associated urinary tract infection, Health, CEO, Partnership, MEDICA, Medical device, Pharmaceutical industry, Medical imaging, N95

Ur24Technology Inc., a privately held medical device company, announced today that it has formed a strategic partnership with DemeTECH Corporation a move that combines market-altering innovation with the power of leadership in surgical products production and a global distribution network.

Key Points: 
  • Ur24Technology Inc., a privately held medical device company, announced today that it has formed a strategic partnership with DemeTECH Corporation a move that combines market-altering innovation with the power of leadership in surgical products production and a global distribution network.
  • More than 4,200 companies will attend the event, which each year highlights innovative products for the healthcare industry.
  • Were excited to join DemeTECH at Medica 2022 and showcase the only catheter of its kind in the world.
  • Under the terms of the partnership, DemeTECH will manufacture Ur24Technologys new external catheters and have exclusive worldwide distribution rights and non-exclusive U.S. distribution right.